Table of content for "Adm tocilizu covid-19 2nd" (HCPCS M0250)
General information on the “M0250” code
HCPCS Code: M0250
Long Description: Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
Short Description: Adm tocilizu covid-19 2nd
Original information is taken from M0250 page
Pricing indicators
Pricing Indicator Code 1: 54 – Vaccinations
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: C – Carrier judgment
Type of service
Berenson-Eggers Type of Service (BETOS): O1G – Immunizations/Vaccinations
Type Of Service 1: V – Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20210624
Code Effective Date: 20210624
Action Code: N – No maintenance for this code